Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Taste receptor type 1 members are a family of G protein-coupled receptors responsible for detecting palatable tastes—primarily sweet and umami. The family consists of three main subunits—TAS1R1, TAS1R2, and TAS1R3—which form functional heterodimers. The TAS1R2+TAS1R3 heterodimer acts as the primary mammalian sweet taste sensor by binding sugars and artificial sweeteners. The TAS1R1+TAS1R3 heterodimer detects umami flavors such as those from amino acids like glutamate. These receptors are expressed mainly on specialized cells within tongue papillae but also have roles elsewhere in nutrient sensing. The ligand-binding domains allow broad yet discriminating chemical recognition through spacious pockets rich in aromatic residues[5][4][2]. Genetic variation within these genes affects individual sensitivity to certain tastes—for example, differences in MSG detection thresholds relate to polymorphisms within TASIIR genes[3]. While not direct drug targets currently used therapeutically, their function is modulated by food additives including natural sugars/sweeteners or flavor enhancers like MSG. No major safety concerns exist regarding pharmacological targeting since they are not clinical drug targets at present. However, their role influences nutrition-related behaviors that could indirectly affect health outcomes such as obesity or metabolic syndrome through altered sugar intake preferences[5][2]
Ligand binding induces conformational change in the heterodimeric GPCR complex (TAS1R2+TAS1R3 for sweet; TAS1R1+TAS1R3 for umami), activating intracellular signaling pathways via G proteins to transmit taste signals to the brain[2][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taste receptor type 1 member (T1R (or TAS1R, depending on context)).